Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

By C. Hadigan, James B. Meigs, C. Corcoran, Petra Rietschel, Sarah Piecuch, N. Basgoz, B. Davis, P. Sax, T. Stanley, Peter W. F. Wilson and 2 more. Clinical Infectious Diseases, 2001

720 citations recorded by the source corpus.

Subfields: Emergency Medicine, Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/e1ed9d5cc6d4b9e622f4f35f171dec7186a62223

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Grundy
2. T. Jacobson
3. V. Triant
4. K. Maki
5. S. Daniels
6. Hang Lee
7. C. Orringer
8. M. Freiberg

Citations in the corpus

• Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. (2007, background): “00/0 The Journal of Clinical Endocrinology & Metabolism 92(7):2506–2512”
• HIV Infection and the Risk of Acute Myocardial Infarction (2013, positive): “Among HIVinfected people, ART is associated with metabolic changes(33) and abnormal fat distribution,(34,35) which in turn are linked with insulin resistance,(33) diabetes,(33) and dyslipidemia.(33,36) Although HIV and ART are associated with AMI risk, results from the Strategies for Management of A”
• Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. (2005, background): “9-year median follow-up period.(8) In that study, case ascertainment was determined by selfreports at semiannual visits.”
• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, background): “Furthermore, patients with lipodystrophy have a greater prevalence of dyslipidemia and impaired glucose metabolism than patients without lipodystrophy.(591) It is unclear what accounts for the association of CD4 count with CVD risk.”